ZIMP
BSX icon

Zimmermann Investment Management & Planning’s Boston Scientific BSX Stock Holding History

Zimmermann Investment Management & Planning’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,621
Closed -$220K – 22
2024
Q3 		$220K Hold
2,621
– – 0.07% 140
2024
Q2 		$202K Buy
+2,621
New +$192K 0.07% 130

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Zimmermann Investment Management & Planning's BSX Position: Q4 2024 in Review

Zimmermann Investment Management & Planning sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 2,621 shares — an estimated $220K sold.

Zimmermann Investment Management & Planning first reported a position in BSX in Q2 2024 and held it in 2 quarters. The position peaked at $220K in Q3 2024. 1,512 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Zimmermann Investment Management & Planning reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Zimmermann Investment Management & Planning sold 2,621 Boston Scientific shares in Q4 2024, an estimated $220K.
  • Zimmermann Investment Management & Planning first reported a position in Boston Scientific in Q2 2024 and held it in 2 quarters.
  • Zimmermann Investment Management & Planning's Boston Scientific position peaked at $220K in Q3 2024.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Zimmermann Investment Management & Planning's 13F filing for Q4 2024, filed 23 Jan 2025.